Trial intelligence / Profile preview

Adalimumab plus methotrexate versus adalimumab alone in moderate-to-severe psoriasis

NL-OMON45239Phase 4Active, not recruiting

Sponsor

Amsterdam University Medical Center

Start

Mar 2014

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1